HP1328
Modify Date: 2025-08-27 16:53:47
HP1328 structure
|
Common Name | HP1328 | ||
|---|---|---|---|---|
| CAS Number | 2245074-20-6 | Molecular Weight | 389.45 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H23N3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HP1328HP1328 is a potent inhibitor of FLT3 receptor tyrosine kinase (FLT3/ITD mutation). HP1328 is a benzoimidazole scaffold-based compound. HP1328 significantly reduces the leukemia burden and prolongs the survival of mice with FLT3/ITD leukemia[1]. |
| Name | HP1328 |
|---|
| Description | HP1328 is a potent inhibitor of FLT3 receptor tyrosine kinase (FLT3/ITD mutation). HP1328 is a benzoimidazole scaffold-based compound. HP1328 significantly reduces the leukemia burden and prolongs the survival of mice with FLT3/ITD leukemia[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C23H23N3O3 |
|---|---|
| Molecular Weight | 389.45 |